23andMe, in bankruptcy, is up for auction again with a $305M bid from co-founder Anne Wojcicki.

23andMe, a genetic testing firm in bankruptcy, is back on the auction block with a new bid from its co-founder Anne Wojcicki. Initially set to sell to Regeneron for $256 million, 23andMe is now seeking higher offers after Wojcicki proposed $305 million through her nonprofit. The sale includes genetic data from about 16 million customers.